Praxair: latest news - GoINPHARMA
Tuesday, 25 September 2018 - 2:23

Praxair

Private equities step forward to acquire Linde-Praxair’s assets

Linde and Praxair are reportedly weighing the sale of some assets in order to avoid issues with antitrust authorities and private equities CVC Capital Partners, Carlyle Group and Advent International are likely to target them. Specifically, CVC is reported to…

Frustration builds for Linde investors

Investors in German group Linde voiced frustration, during their meeting, for the merger with competitor Praxair slowing down. The management, yet, said that the merger remains on track, delayed by only a week, despite stiff opposition by labor representatives, afraid…

Teva exploring sale of oncology business

Teva Pharmaceuticals is reportedly weighing a sale of its cancer therapies business. The division delivered sales of $1.14bn in 2016 (-5% vs 2015). The divestiture reportedly addresses the need to reduce debt, due to the $40.5bn acquisition of Allergan’s generics…

Linde-Praxair merger at risk

German-based group Linde labor representatives could block the merger with US-based Praxair. The economic and financial daily Handelsblatt reported that the spokesperson of the German works council (Konzernbetriebsrat), Gernot Hahl, voiced in an open letter his concerns that a merger…

$65bn merger of equals between Praxair and Linde

Praxair and Linde announced today a merger of equals (50:50), meeting widespread expectations. The deal creates a $65bn-worth group, the world’s largest supplier of industrial and medical gases. The new entity will have its headquarters in Danbury, Connecticut, while its…

In surprise move, Praxair resumes talks with Linde

With a surprising move, Praxair restarted negotiations with competitor Linde over a combination that would create a $60bn leader in the medical and industrial gases business. Linde, indeed, has approximately $29bn in market capitalization, while Praxair has $34.6bn. The talks…

Revolution in Linde board following failed merger with Praxair

Two top executives at Linde will leave the group following the failure of the takeover attempt by rival Praxair, that would have created a $60bn group, leader in the technical and medical gases business. The supervisory board (Aufsichtsrat) decided yesterday…

Praxair-Linde merger failed

Germany-based Linde and U.S.-based Praxair have informed investors and analysts in two almost simultaneous press releases that talks on a potential merger have been interrupted. Linde and Praxair confirmed on August 16 rumors about a potential merger that would create…